Area of research
Molecular Biology · Hematology
Research interest
Research interests include Cancer research, Biology, Prostate cancer, Androgen receptor, SMARCA4, and FOXA1.
Therapeutic benefit of the dual ALK/FAK inhibitor ESK440 in ALK-driven neuroblastoma
Author Correction: Targeting SWI/SNF ATPases in enhancer-addicted prostate cancer
Discovery of a Highly Potent and Selective Dual PROTAC Degrader of CDK12 and CDK13
Targeting SWI/SNF ATPases in enhancer-addicted prostate cancer
Targeting transcriptional regulation of SARS-CoV-2 entry factors<i>ACE2</i>and<i>TMPRSS2</i>
Androgen receptor degraders overcome common resistance mechanisms developed during prostate cancer treatment
An essential role for Argonaute 2 in EGFR-KRAS signaling in pancreatic cancer development
Characterizing the Therapeutic Potential of a Potent BET Degrader in Merkel Cell Carcinoma
EWS/ETS-Driven Ewing Sarcoma Requires BET Bromodomain Proteins
miR-34a directly targets tRNA <sub>i</sub> <sup>Met</sup> precursors and affects cellular proliferation, cell cycle, and apoptosis
Development of Peptidomimetic Inhibitors of the ERG Gene Fusion Product in Prostate Cancer